Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection

Yuanyuan Yu(Ningxia Medical University), Guangyu Wang(Tongji University), Jie Sun(Wenzhou Medical University), Yue Ma(Harbin Medical University), Qianhao Meng(Harbin Medical University), Xiaona Fan(Harbin Medical University), Zicheng Zhang(Hunan Agricultural University)
Frontiers in Oncology
May 24, 2021
Cited by 3


Related Papers